USD
$0.00
(0.00%
)At Close (As of Oct 13, 2025)
$5.51M
Market Cap
-
P/E Ratio
-105.51
EPS
$44.64
52 Week High
$0.73
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Operating Cashflow | -$3M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $920K |
Capital Expenditures | $184K |
Change In Receivables | - |
Change In Inventory | $45K |
Profit Loss | - |
Cashflow From Investment | $364K |
Cashflow From Financing | $3.1M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$9.1M |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
INVO Fertility, Inc. is a leading healthcare services provider specializing in the fertility sector, offering innovative assisted reproductive technology solutions to enhance patient outcomes. With its headquarters located in Sarasota, Florida, INVO Fertility is committed to advancing fertility care through its proprietary INVOcell® technology, which allows for a more accessible and cost-effective approach to in vitro fertilization. The company aims to meet the growing demand for reproductive services while maintaining a patient-centric focus and fostering partnerships within the healthcare community.